BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Haggar SM, Hegazy SK, M Abd-Elsalam S, Bahaa MM. Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. J Clin Pharm Ther 2021. [PMID: 34726293 DOI: 10.1111/jcpt.13556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nabizadeh H, Mohammadi A, Dolatabadi R, Nojavan S, Vahabizad F. Sensitive determination of ethosuximide in human fluids by electromembrane extraction coupled with high performance liquid chromatography ultraviolet spectroscopy. J Chinese Chemical Soc 2022. [DOI: 10.1002/jccs.202200423] [Reference Citation Analysis]
2 El-haggar SM, Hegazy SK, Abd-elsalam SM, Elkaeed EB, Al-karmalawy AA, Bahaa MM. A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. JIR 2022;Volume 15:1159-72. [DOI: 10.2147/jir.s346608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hoppanova L, Lacinova L. Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways. Pflugers Arch 2022. [PMID: 35043234 DOI: 10.1007/s00424-022-02666-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]